Fluorescence-enhanced covalent organic framework
nanosystem for tumor imaging and photothermal therapy
Liu, Y (Liu, Yang)[ 1 ] ; Zhang, YP (Zhang, Yapei)[ 1 ] ; Li, XM (Li, Xiaomin)[ 1 ] ; Gao, XF (Gao, Xuefeng)[ 1 ] ; Niu, XY (Niu, Xiaoyan)[ 1 ] ; Wang, W (Wang, Wei)[ 1 ] ; Wu, Q (Wu, Qiang)[ 1 ] ; Yuan, Z (Yuan, Zhi)[ 1,2 ]
NANOSCALE, 2019, 11(21): 10429-10438
DOI: 10.1039/c9nr02140j
Abstract
Fluorescent
dyes, as a key factor in fluorescence imaging, usually exhibit a low signal-to-noise
ratio (SNR) due to the limited loading capacities of delivery systems (usually
less than 10.0 wt%) and their uncontrolled release. Herein, we developed a type
of pH-responsive nanoplatform (MnO2/ZnCOF@ Au& BSA) based on a zinc
porphyrin covalent organic framework (COF), in which the zinc porphyrin (ZnPor)
loading rate is 22.5 wt%. At pH = 7.4, the interlinked ZnPor in the assembly
state did not show a fluorescence signal (" off" state). Together
with the pH-triggered disintegration of ZnCOF in tumor cells (pH = 5.5), the
scattered ZnPor displayed an obvious fluorescence signal recovery ("
on" state). Simultaneously, the shed BSA-coated gold nanoparticles
ingeniously caused the fluorescence signal to be further amplified through the
metal-enhanced fluorescence effect, which was about 3.0-fold higher in vivo
than in the free ZnPor group. Combined with the excellent photothermal therapy
effect by the nanoplatform itself with the tumor inhibition rate of 79.5%, this
nanosystem effectively solves the problem of low loading capacities and imaging
SNR by traditional delivery systems, and successfully develops the potential of
COFs for fluorescence imaging, achieving the purpose of integration of
diagnosis and treatment.